Title : A randomized, double-blind, placebo-controlled, parallel study to assess the efficacy and safety of once-a-day tadalafil in men with erectile dysfunction who are naïve to PDE5 inhibitors.

Pub. Date : 2011 Sep

PMID : 21707928






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 AIM: To evaluate the efficacy and safety of once-a-day tadalafil in PDE5 inhibitor-naive men with erectile dysfunction (ED). Tadalafil phosphodiesterase 5A Homo sapiens
2 CONCLUSIONS: In PDE5 inhibitor-naive men, tadalafil once a day significantly improved EF compared with placebo. Tadalafil phosphodiesterase 5A Homo sapiens